Alentis Therapeutics

The Senior Manager Biosample Management will lead the strategic and operational oversight of the full end-to-end lifecycle for all clinical bio samples supporting pharmacokinetics (PK) anti-drug antibody (ADA)/immunogenicity and biomarker analyses across Alentis Therapeutics clinical

The Senior Manager Biosample Management will lead the strategic and operational oversight of the full end-to-end lifecycle for all clinical bio samples supporting pharmacokinetics (PK) anti-drug antibody (ADA)/immunogenicity and biomarker analyses across Alentis Therapeutics clinical

The Senior Manager Biosample Management will lead the strategic and operational oversight of the full end-to-end lifecycle for all clinical bio samples supporting pharmacokinetics (PK) anti-drug antibody (ADA)/immunogenicity and biomarker analyses across Alentis Therapeutics clinical

The Senior Manager Biosample Management will lead the strategic and operational oversight of the full end-to-end lifecycle for all clinical bio samples supporting pharmacokinetics (PK) anti-drug antibody (ADA)/immunogenicity and biomarker analyses across Alentis Therapeutics clinical

We are looking for a Laboratory Manager (80-100%) reporting to the Senior Director Translational Research.The laboratory manager will oversee all tasks related to supporting the day-to-day operations of the laboratory. She/He will establish the quality standards aimed at maintaining t

We are looking for a Laboratory Manager (80-100%) reporting to the Senior Director Translational Research.The laboratory manager will oversee all tasks related to supporting the day-to-day operations of the laboratory. She/He will establish the quality standards aimed at maintaining t

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1